Abstract:Osteopenia and osteoporosis are among the most common metabolic bone diseases and represent major public health problems, with sufferers having an increased fracture risk. Diabetes is one of the most common diseases contributing to osteopenia and osteoporosis. However, the mechanisms underlying diabetes-induced osteopenia and osteoporosis remain unclear. Bone reconstruction, including bone formation and absorption, is a dynamic process. Large-conductance Ca 2+ -activated K + channels (BK channels) regulate the function of bone marrow-derived mesenchymal stem cells, osteoblasts, and osteoclasts. Our previous studies revealed the relationship between BK channels and the function of osteoblasts via various pathways under physiological conditions. In this study, we reported a decrease in the expression of BK channels in mice with diabetes-induced osteopenia. BK deficiency enhanced mitochondrial Ca 2+ and activated classical PINK1 (PTEN induced putative kinase 1)-PRKN/Parkin (parkin RBR E3 ubiquitin protein ligase)-dependent mitophagy, whereas the upregulation of BK channels inhibited mitophagy in osteoblasts. Moreover, SLC25A5/ANT2 (solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5), a critical inner mitochondrial membrane protein participating in PINK1-PRKN-dependent mitophagy, was also regulated by BK channels. Overall, these data identified a novel role of BK channels in regulating mitophagy in osteoblasts, which might be a potential target for diabetes-induced bone diseases. Abbreviations : AGE, advanced glycation end products; Baf A1, bafilomycin A 1 ; BK channels, big-conductance Ca 2+ -activated K + channels; BMSCs, bone marrow-derived mesenchymal stem cells; BSA, bovine serum albumin; FBG, fasting blood glucose; IMM, inner mitochondrial membrane; ITPR1, inositol 1,4,5-trisphosphate receptor 1; MAM, mitochondria-associated ER membrane; OMM, outer mitochondrial membrane; PINK1, PTEN induced putative kinase 1; PPID/CyP-D, peptidylprolyl isomerase D (cyclophilin D); PRKN/PARK2, parkin RBR E3 ubiquitin protein ligase; ROS, reactive oxygen species; SLC25A5/ANT2, solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5; STZ, streptozotocin.

Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice Corrigendum in /10.3892/ijmm.2019.4091

Bradykinin Receptors and EphB2/EphrinB2 Pathway in Response to High Glucose-Induced Osteoblast Dysfunction and Hyperglycemia-Induced Bone Deterioration in Mice

High Glucose Conditions Suppress the Function of Bone Marrow-Derived Endothelial Progenitor Cells Via Inhibition of the Enos-Caveolin-1 Complex.

Hyperglycemia Induces Endoplasmic Reticulum Stress-Dependent CHOP Expression in Osteoblasts

Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro

Hyperglycemia impairs osteoblast cell migration and chemotaxis due to a decrease in mitochondrial biogenesis

Investigation for GSK3β Expression in Diabetic Osteoporosis and Negative Osteogenic Effects of GSK3β on Bone Marrow Mesenchymal Stem Cells under a High Glucose Microenvironment.

The Inhibition of PINK1/Drp1-mediated Mitophagy by Hyperglycemia Leads to Impaired Osteoblastogenesis in Diabetes

Local Bone Interaction Between Renin-Angiotensin System and Kallikrein-Kinin System in Diabetic Rat.

Osteoblast-intrinsic defect in glucose metabolism impairs bone formation in type II diabetic male mice

The Role of Wnt Signaling in Diabetes-Induced Osteoporosis

Analysis of bone metabolic alterations linked with osteoporosis progression in type 2 diabetic db/db mice

Mechanism of Endoplasmic Reticulum Stress in the Pathogenesis of Diabetic Osteoporosis

Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis.

Hyperglycemia Induces Osteoclastogenesis and Bone Destruction Through the Activation of Ca2+/Calmodulin-Dependent Protein Kinase II.

High Glucose Impaired Estrogen Receptor Alpha Signaling Via Β-Catenin in Osteoblastic MC3T3-E1

Osteoking prevents bone loss and enhances osteoblastic bone formation by modulating the AGEs/IGF-1/β-catenin/OPG pathway in type 2 diabetic db/db mice

Activation of BK channels prevents diabetes-induced osteopenia by regulating mitochondrial Ca2+ and SLC25A5/ANT2-PINK1-PRKN-mediated mitophagy

Differential Responses Of Bone To Angiotensin Ii And Angiotensin(1-7): Beneficial Effects Of Ang(1-7) On Bone With Exposure To High Glucose

Advanced glycation end products mediate biomineralization disorder in diabetic bone disease

High Insulin Levels in KK-Ay Diabetic Mice Cause Increased Cortical Bone Mass and Impaired Trabecular Micro-Structure